These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy. Wengert ER, Saga AU, Panchal PS, Barker BS, Patel MK. Neuropharmacology; 2019 Nov 01; 158():107699. PubMed ID: 31278928 [Abstract] [Full Text] [Related]
24. Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons. Tidball AM, Lopez-Santiago LF, Yuan Y, Glenn TW, Margolis JL, Clayton Walker J, Kilbane EG, Miller CA, Martina Bebin E, Scott Perry M, Isom LL, Parent JM. Brain; 2020 Oct 01; 143(10):3025-3040. PubMed ID: 32968789 [Abstract] [Full Text] [Related]
25. Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy. Thompson JA, Miralles RM, Wengert ER, Wagley PK, Yu W, Wenker IC, Patel MK. Epilepsia Open; 2022 Jun 01; 7(2):280-292. PubMed ID: 34826216 [Abstract] [Full Text] [Related]
26. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG. Cochrane Database Syst Rev; 2017 Jun 29; 6(6):CD011412. PubMed ID: 28661008 [Abstract] [Full Text] [Related]
27. Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures. Denis J, Villeneuve N, Cacciagli P, Mignon-Ravix C, Lacoste C, Lefranc J, Napuri S, Damaj L, Villega F, Pedespan JM, Moutton S, Mignot C, Doummar D, Lion-François L, Gataullina S, Dulac O, Martin M, Gueden S, Lesca G, Julia S, Cances C, Journel H, Altuzarra C, Ben Zeev B, Afenjar A, Barth M, Villard L, Milh M. Epilepsia; 2019 May 29; 60(5):845-856. PubMed ID: 31026061 [Abstract] [Full Text] [Related]
28. Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach. Boerma RS, Braun KP, van den Broek MP, van Berkestijn FM, Swinkels ME, Hagebeuk EO, Lindhout D, van Kempen M, Boon M, Nicolai J, de Kovel CG, Brilstra EH, Koeleman BP. Neurotherapeutics; 2016 Jan 29; 13(1):192-7. PubMed ID: 26252990 [Abstract] [Full Text] [Related]
31. Long-Term Downregulation of the Sodium Channel Gene Scn8a Is Therapeutic in Mouse Models of SCN8A Epilepsy. Hill SF, Yu W, Ziobro J, Chalasani S, Reger F, Meisler MH. Ann Neurol; 2024 Apr 29; 95(4):754-759. PubMed ID: 38113311 [Abstract] [Full Text] [Related]
32. Biallelic inherited SCN8A variants, a rare cause of SCN8A-related developmental and epileptic encephalopathy. Wengert ER, Tronhjem CE, Wagnon JL, Johannesen KM, Petit H, Krey I, Saga AU, Panchal PS, Strohm SM, Lange J, Kamphausen SB, Rubboli G, Lemke JR, Gardella E, Patel MK, Meisler MH, Møller RS. Epilepsia; 2019 Nov 29; 60(11):2277-2285. PubMed ID: 31625145 [Abstract] [Full Text] [Related]
33. Complex biophysical changes and reduced neuronal firing in an SCN8A variant associated with developmental delay and epilepsy. Quinn S, Zhang N, Fenton TA, Brusel M, Muruganandam P, Peleg Y, Giladi M, Haitin Y, Lerche H, Bassan H, Liu Y, Ben-Shalom R, Rubinstein M. Biochim Biophys Acta Mol Basis Dis; 2024 Jun 29; 1870(5):167127. PubMed ID: 38519006 [Abstract] [Full Text] [Related]
34. Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. Hill SF, Jafar-Nejad P, Rigo F, Meisler MH. Front Neurosci; 2023 Jun 29; 17():1282201. PubMed ID: 37901435 [Abstract] [Full Text] [Related]
35. SCN8A Mutation in Infantile Epileptic Encephalopathy: Report of Two Cases. Fatema K, Rahman MM, Faruk O. J Epilepsy Res; 2019 Dec 29; 9(2):147-151. PubMed ID: 32509551 [Abstract] [Full Text] [Related]